Plot Summary
The Great Cholesterol Myth: Why Lowering Your Cholesterol Won't Prevent Heart Disease-And the Statin-Free Plan That Will
Jonny Bowden, Stephen Sinatra
The Great Cholesterol Myth: Why Lowering Your Cholesterol Won't Prevent Heart Disease-And the Statin-Free Plan That Will
Nonfiction | Book | Adult | Published in 2012
Plot Summary
This revised and expanded edition challenges the belief that cholesterol causes heart disease and that statin drugs, a class of cholesterol-lowering medications, are the appropriate treatment. Nutritionist Jonny Bowden and cardiologist Stephen Sinatra argue that the real drivers of heart disease are inflammation, oxidation, sugar, and insulin resistance, a condition in which cells respond poorly to the hormone insulin. The book proceeds in three parts: The first reexamines what cholesterol is; the second identifies sugar as the primary dietary threat and critiques statin drugs; the third offers dietary, supplement, and lifestyle recommendations.
The foreword, by physicians Michael R. and Mary Dan Eades, compares the fixation on lowering cholesterol to the centuries-long practice of bloodletting. The lipid hypothesis, proposed by researcher Ancel Keys in the mid-20th century, holds that saturated fat raises cholesterol and elevated cholesterol causes heart disease. The foreword contends that cholesterol is an essential molecule, synthesized by nearly every cell, serving as a precursor to bile acids, vitamin D, and steroid hormones.
In Chapter 1, the authors note that technology now identifies at least 13 cholesterol subtypes, yet most doctors rely on the outdated two-category test for HDL (high-density lipoprotein) and LDL (low-density lipoprotein). They introduce the book's central thesis: Insulin resistance typically precedes type 2 diabetes, and diabetes is effectively "pre-heart disease," since more than 80 percent of diabetics die of cardiovascular disease. The authors urge testing for insulin resistance, which can reveal problems years or decades before a diagnosis.
Chapter 2 presents both authors' journeys from believers in the cholesterol hypothesis to skeptics. Bowden, a former personal trainer, saw a client improve on the high-fat Atkins diet, contradicting conventional teachings. The Lyon Diet Heart Study achieved a 70 percent reduction in deaths without changing cholesterol levels, and the Nurses' Health Study identified five factors accounting for 82 percent of coronary events, none involving cholesterol lowering. Sinatra, formerly a paid consultant for statin manufacturers, grew skeptical after observing patients with very low cholesterol developing heart disease and discovering that statins deplete coenzyme Q₁₀ (CoQ₁₀), a nutrient critical for heart function.
Chapter 3 traces how the diet-heart hypothesis became entrenched despite weak evidence. Most nutrition policy rests on epidemiological studies, which show association but not causation. Researcher Ivan Frantz conducted a randomized controlled trial finding no benefit from replacing saturated fat with vegetable oil; in people over 65, those who lowered cholesterol the most had the highest risk of dying. Frantz's data went unpublished until National Institutes of Health (NIH) researcher Christopher Ramsden recovered them decades later. In 2015, the U.S. government acknowledged that dietary cholesterol is no longer considered a nutrient of concern for overconsumption.
Chapter 4 explains cholesterol biology. Because cholesterol is hydrophobic, the body transports it in lipoproteins, cholesterol-carrying particles in the bloodstream, and the total number of particles, not their cholesterol content, is the critical metric. The authors advocate for the NMR (nuclear magnetic resonance) particle test and highlight the triglyceride-to-HDL ratio (triglycerides being a type of fat that circulates in the blood) as a predictor of heart disease and insulin resistance. The chapter describes atherosclerosis, the buildup of plaque in artery walls: An irritant damages the endothelium, the inner lining of arteries, allowing LDL particles to penetrate. Immune cells consume the intruders, die, and form foam cells that accumulate into plaque, which becomes dangerous when it ruptures and blocks blood flow.
Chapter 5 argues that inflammation and oxidation drive heart disease. Only oxidized LDL initiates the inflammatory cascade in arteries, explaining the "smoker's paradox": Smokers with normal LDL face higher risk than nonsmokers with elevated LDL because cigarette smoke oxidizes LDL. The chapter introduces glycation, the process by which excess blood sugar attaches to LDL, creating a stickier form more common in people with type 2 diabetes.
Chapter 6 argues that sugar is the real dietary villain. Insulin rises sharply in response to sugar and processed carbohydrates; chronic overconsumption leads to insulin resistance, raising blood pressure, increasing triglycerides, and promoting arterial inflammation. The chapter exposes the sugar industry's campaign to suppress evidence linking sugar to heart disease, citing documents showing the Sugar Research Foundation secretly funded a 1967 Harvard review exonerating sugar and blaming fat. Fructose is identified as especially dangerous because it goes directly to the liver, promotes fatty liver, and drives insulin resistance.
Chapter 7 challenges the demonization of dietary fat. Multiple meta-analyses, including a 2010 study of 347,747 subjects, find no association between saturated fat intake and heart disease. The real problem is the imbalance between pro-inflammatory omega-6 fatty acids from vegetable oils and anti-inflammatory omega-3s, with Western diets reaching ratios of 20:1 instead of the ideal 1:1 to 4:1.
Chapter 8 critiques statin drugs. The authors acknowledge two genuine benefits, mild anti-inflammatory effects and reduced blood viscosity, but argue these, not cholesterol lowering, account for any observed benefits. Side effects include cognitive impairment, CoQ₁₀ depletion, sexual dysfunction, and associations with increased cancer and diabetes risk. Relative risk statistics exaggerate benefits: Lipitor's "36 percent reduction in heart attack risk" translates to an absolute reduction of approximately 1 percent. The authors conclude statins should be prescribed only to middle-aged men who have already had a heart attack or have documented coronary artery disease.
Chapter 9 presents insulin resistance as the real cause of heart disease. Chicago pathologist Joseph R. Kraft, who tested more than 14,000 people over 35 years, concluded that heart disease patients not identified as diabetic "are simply undiagnosed." Stanford researcher Gerald Reaven showed that subjects with high insulin resistance had a 40-fold increase in heart disease risk, while those with healthy insulin response had zero clinical events over seven years. The authors recommend a fasting insulin test combined with fasting glucose, entered into a HOMA-2 calculator, a tool that estimates insulin resistance from those values.
In Part Three, the authors turn to solutions. Chapter 10 recommends eliminating sugar, soda, processed carbohydrates, trans fats, and processed meats while emphasizing wild salmon, berries, grass-fed beef, vegetables, nuts, beans, dark chocolate, turmeric, garlic, olive oil, and green tea. Chapter 11 recommends supplements, led by the "Awesome Foursome" of metabolic cardiology, an approach supporting heart energy metabolism: CoQ₁₀, D-ribose (a sugar molecule that helps build ATP, the body's energy currency), L-carnitine (a compound that shuttles fatty acids into cells for energy production), and magnesium. Additional recommendations include niacin, fish oil providing the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), curcumin (turmeric's anti-inflammatory compound), resveratrol (a plant antioxidant), and berberine (a plant compound for blood-sugar control).
Chapter 12 argues that emotional and psychological factors matter as much as diet. Grounded in psychoneuroimmunology, the study of how thoughts affect the immune system, the chapter contends that chronic stress drives inflammation and elevated blood pressure. The authors recommend deep breathing and meditation, citing cardiologist Herbert Benson's research on the "Relaxation Response," a state of deep rest achieved through quiet breathing and mental repetition. They also advocate for laughing, crying, expressive writing, massage, unstructured play, an active sex life, and HeartMath biofeedback technology, which uses real-time heart rate monitoring to reduce stress.
The appendices provide additional resources. Appendix A analyzes major statin trials including ALLHAT (a large-scale cholesterol trial in which no lives were saved), ASCOT-LLA (a Lipitor trial with no difference in deaths), PROSPER (a trial in older adults showing increased cancer risk), and JUPITER (a Crestor primary-prevention trial with an absolute risk reduction of only 0.9 percent). Appendix B recommends diagnostic tests including the NMR particle test, C-reactive protein (an inflammation marker), fibrinogen (a clotting protein), serum ferritin (a marker of iron stores), Lp(a) (a genetic lipoprotein risk factor), homocysteine (an amino acid linked to cardiovascular risk), interleukin-6 (an inflammatory marker), and coronary calcium scans.
The foreword, by physicians Michael R. and Mary Dan Eades, compares the fixation on lowering cholesterol to the centuries-long practice of bloodletting. The lipid hypothesis, proposed by researcher Ancel Keys in the mid-20th century, holds that saturated fat raises cholesterol and elevated cholesterol causes heart disease. The foreword contends that cholesterol is an essential molecule, synthesized by nearly every cell, serving as a precursor to bile acids, vitamin D, and steroid hormones.
In Chapter 1, the authors note that technology now identifies at least 13 cholesterol subtypes, yet most doctors rely on the outdated two-category test for HDL (high-density lipoprotein) and LDL (low-density lipoprotein). They introduce the book's central thesis: Insulin resistance typically precedes type 2 diabetes, and diabetes is effectively "pre-heart disease," since more than 80 percent of diabetics die of cardiovascular disease. The authors urge testing for insulin resistance, which can reveal problems years or decades before a diagnosis.
Chapter 2 presents both authors' journeys from believers in the cholesterol hypothesis to skeptics. Bowden, a former personal trainer, saw a client improve on the high-fat Atkins diet, contradicting conventional teachings. The Lyon Diet Heart Study achieved a 70 percent reduction in deaths without changing cholesterol levels, and the Nurses' Health Study identified five factors accounting for 82 percent of coronary events, none involving cholesterol lowering. Sinatra, formerly a paid consultant for statin manufacturers, grew skeptical after observing patients with very low cholesterol developing heart disease and discovering that statins deplete coenzyme Q₁₀ (CoQ₁₀), a nutrient critical for heart function.
Chapter 3 traces how the diet-heart hypothesis became entrenched despite weak evidence. Most nutrition policy rests on epidemiological studies, which show association but not causation. Researcher Ivan Frantz conducted a randomized controlled trial finding no benefit from replacing saturated fat with vegetable oil; in people over 65, those who lowered cholesterol the most had the highest risk of dying. Frantz's data went unpublished until National Institutes of Health (NIH) researcher Christopher Ramsden recovered them decades later. In 2015, the U.S. government acknowledged that dietary cholesterol is no longer considered a nutrient of concern for overconsumption.
Chapter 4 explains cholesterol biology. Because cholesterol is hydrophobic, the body transports it in lipoproteins, cholesterol-carrying particles in the bloodstream, and the total number of particles, not their cholesterol content, is the critical metric. The authors advocate for the NMR (nuclear magnetic resonance) particle test and highlight the triglyceride-to-HDL ratio (triglycerides being a type of fat that circulates in the blood) as a predictor of heart disease and insulin resistance. The chapter describes atherosclerosis, the buildup of plaque in artery walls: An irritant damages the endothelium, the inner lining of arteries, allowing LDL particles to penetrate. Immune cells consume the intruders, die, and form foam cells that accumulate into plaque, which becomes dangerous when it ruptures and blocks blood flow.
Chapter 5 argues that inflammation and oxidation drive heart disease. Only oxidized LDL initiates the inflammatory cascade in arteries, explaining the "smoker's paradox": Smokers with normal LDL face higher risk than nonsmokers with elevated LDL because cigarette smoke oxidizes LDL. The chapter introduces glycation, the process by which excess blood sugar attaches to LDL, creating a stickier form more common in people with type 2 diabetes.
Chapter 6 argues that sugar is the real dietary villain. Insulin rises sharply in response to sugar and processed carbohydrates; chronic overconsumption leads to insulin resistance, raising blood pressure, increasing triglycerides, and promoting arterial inflammation. The chapter exposes the sugar industry's campaign to suppress evidence linking sugar to heart disease, citing documents showing the Sugar Research Foundation secretly funded a 1967 Harvard review exonerating sugar and blaming fat. Fructose is identified as especially dangerous because it goes directly to the liver, promotes fatty liver, and drives insulin resistance.
Chapter 7 challenges the demonization of dietary fat. Multiple meta-analyses, including a 2010 study of 347,747 subjects, find no association between saturated fat intake and heart disease. The real problem is the imbalance between pro-inflammatory omega-6 fatty acids from vegetable oils and anti-inflammatory omega-3s, with Western diets reaching ratios of 20:1 instead of the ideal 1:1 to 4:1.
Chapter 8 critiques statin drugs. The authors acknowledge two genuine benefits, mild anti-inflammatory effects and reduced blood viscosity, but argue these, not cholesterol lowering, account for any observed benefits. Side effects include cognitive impairment, CoQ₁₀ depletion, sexual dysfunction, and associations with increased cancer and diabetes risk. Relative risk statistics exaggerate benefits: Lipitor's "36 percent reduction in heart attack risk" translates to an absolute reduction of approximately 1 percent. The authors conclude statins should be prescribed only to middle-aged men who have already had a heart attack or have documented coronary artery disease.
Chapter 9 presents insulin resistance as the real cause of heart disease. Chicago pathologist Joseph R. Kraft, who tested more than 14,000 people over 35 years, concluded that heart disease patients not identified as diabetic "are simply undiagnosed." Stanford researcher Gerald Reaven showed that subjects with high insulin resistance had a 40-fold increase in heart disease risk, while those with healthy insulin response had zero clinical events over seven years. The authors recommend a fasting insulin test combined with fasting glucose, entered into a HOMA-2 calculator, a tool that estimates insulin resistance from those values.
In Part Three, the authors turn to solutions. Chapter 10 recommends eliminating sugar, soda, processed carbohydrates, trans fats, and processed meats while emphasizing wild salmon, berries, grass-fed beef, vegetables, nuts, beans, dark chocolate, turmeric, garlic, olive oil, and green tea. Chapter 11 recommends supplements, led by the "Awesome Foursome" of metabolic cardiology, an approach supporting heart energy metabolism: CoQ₁₀, D-ribose (a sugar molecule that helps build ATP, the body's energy currency), L-carnitine (a compound that shuttles fatty acids into cells for energy production), and magnesium. Additional recommendations include niacin, fish oil providing the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), curcumin (turmeric's anti-inflammatory compound), resveratrol (a plant antioxidant), and berberine (a plant compound for blood-sugar control).
Chapter 12 argues that emotional and psychological factors matter as much as diet. Grounded in psychoneuroimmunology, the study of how thoughts affect the immune system, the chapter contends that chronic stress drives inflammation and elevated blood pressure. The authors recommend deep breathing and meditation, citing cardiologist Herbert Benson's research on the "Relaxation Response," a state of deep rest achieved through quiet breathing and mental repetition. They also advocate for laughing, crying, expressive writing, massage, unstructured play, an active sex life, and HeartMath biofeedback technology, which uses real-time heart rate monitoring to reduce stress.
The appendices provide additional resources. Appendix A analyzes major statin trials including ALLHAT (a large-scale cholesterol trial in which no lives were saved), ASCOT-LLA (a Lipitor trial with no difference in deaths), PROSPER (a trial in older adults showing increased cancer risk), and JUPITER (a Crestor primary-prevention trial with an absolute risk reduction of only 0.9 percent). Appendix B recommends diagnostic tests including the NMR particle test, C-reactive protein (an inflammation marker), fibrinogen (a clotting protein), serum ferritin (a marker of iron stores), Lp(a) (a genetic lipoprotein risk factor), homocysteine (an amino acid linked to cardiovascular risk), interleukin-6 (an inflammatory marker), and coronary calcium scans.
We’re just getting started
Add this title to our list of requested Study Guides!